sb 203580 has been researched along with Neutropenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bierings, MB; Bruin, MC; Buitenhuis, M; Coffer, PJ; Geest, CR; Laarhoven, AG; Vellenga, E | 1 |
1 other study(ies) available for sb 203580 and Neutropenia
Article | Year |
---|---|
p38 MAP kinase inhibits neutrophil development through phosphorylation of C/EBPalpha on serine 21.
Topics: Animals; Apoptosis; Blotting, Western; CCAAT-Enhancer-Binding Protein-alpha; Cell Differentiation; Cells, Cultured; Enzyme Inhibitors; Eosinophils; Humans; Imidazoles; Immunohistochemistry; MAP Kinase Kinase 3; Mice; Mice, Inbred NOD; Mice, SCID; Myelopoiesis; Neutropenia; Neutrophils; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Respiratory Burst; Serine | 2009 |